Nuzenio

Marketbeat Collegium Pharmaceutical

Marketbeat Collegium Pharmaceutical news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Collegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTNeedham & Company LLC Cuts Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $46.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 19:18:00 GMTCollegium Pharmaceutical Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 13:04:01 GMTZacks Research Downgrades Collegium Pharmaceutical (NASDAQ:COLL) to Hold - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 04:52:38 GMTCollegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Thu, 06 Aug 2026 19:18:00 GMTNeedham & Company LLC Cuts Collegium Pharmaceutical (NASDAQ:COLL) Price Target to $46.00 - MarketBeat
Thu, 06 Aug 2026 13:04:01 GMTCollegium Pharmaceutical Q2 Earnings Call Highlights - TradingView
Thu, 30 Jul 2026 07:00:00 GMTZacks Research Downgrades Collegium Pharmaceutical (NASDAQ:COLL) to Hold - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Collegium Pharmaceutical.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.